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Abstract In general, gene-expression microarrays
consist of a vast number of genes and very few sam-
ples, which represents a critical challenge for dis-
ease prediction and diagnosis. This paper develops
a two-stage algorithm that integrates feature selec-
tion and prediction by extending a type of hetero-
associative neural networks. In the first level, the al-
gorithm generates the associative memory, whereas
the second level picks the most relevant genes. With
the purpose of illustrating the applicability and ef-
ficiency of the method proposed here, we use four
different gene-expression microarray databases and
compare its classification performance against that
of other renowned classifiers built on the whole (orig-
inal) feature (gene) space. The experimental results
show that the two-stage hetero-associative memory
is quite competitive with standard classification mod-
els regarding the overall accuracy, sensitivity, and
specificity. In addition, it also produces a significant
decrease in computational efforts and an increase
in the biological interpretability of microarrays be-
cause worthless (irrelevant and/or redundant) genes
are discarded.
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1 Introduction
Gene-expression microarray is a high-throughput ge-
nomic technology in research and clinical manage-
ment that allows to record and monitor the expres-
sion levels of thousands of genes simultaneously
within a few different samples. The expression level
of a gene can be viewed as an estimate of the con-
centration of its mRNA transcript in a cell at a given
time. The primary objective of using microarrays is
to classify or predict the category of a sample based
on its gene-expression profile. A plethora of compu-
tational methods have been applied to the analysis
of microarrays [31,18], and in particular to discrim-
inate between cancerous and non-cancerous tissues,
to characterize distinct types or subtypes of tumors,
and even to predict the reaction to a specific thera-
peutic drug and the risk of relapse [9,33,37,46].
Nonetheless, the use of microarrays for classifi-
cation poses a crucial computational challenge aris-
ing from the huge number of genes (G) and the lim-
ited quantity of samples (n) [14]. The number of
genes is usually of the order of thousands, but the
number of samples is below a hundred. This prob-
lem is known as the ‘large G, small n’ or ‘curse of
dimensionality’ phenomenon, which increases the
difficulty of classification significantly, degrades the
generalization capability of classifiers and hinders
the understanding of the relationships between genes
and samples [38,13,23,16]. Moreover, only a few
relevant genes are needed [47,5,7,17]. The most
common practice to address this question is to use
some feature (gene) selection method by choosing
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a small portion of informative variables that con-
tribute most to any subsequent task for clinical iden-
tification, classification, prediction or interpretation.
Feature selection focuses on the deletion of ir-
relevant, noisy and redundant genes from the mi-
croarrays with the aim of preserving the genes that
best discriminate samples of different classes (tis-
sue categories, disease states or clinical outcomes).
Besides, it also helps to identify patterns of gene
expression associated with a particular disease. On
the other hand, it has to be remarked that the need of
applying feature selection is imperative in the case
of gene-expression microarrays not only owing to
the extremely large number of input variables, but
also because a considerable amount of them can be
highly correlated with other variables. Over the last
decades, many different algorithms have been de-
veloped for gene selection using filter, wrapper, em-
bedded and hybrid methods [5,7,35,39,49,30,43,
19].
In the present paper, we introduce a technique
to classify the gene-expression microarray data with
a two-stage associative memory. The first stage in-
volves the construction of a hybrid associative neu-
ral network, whereas the second stage allows for
the selection of the most relevant (differentially ex-
pressed) genes for the classification of the tissue
samples. Thus the purpose of this study is two-fold:
(i) to analyze the practicability of this hybrid con-
nectionist model when applied to the classification
of gene-expression microarrays, and (ii) to compare
its performance with that of several standard predic-
tion algorithms that are widely used in the biomed-
ical domain.
Following the general definition given in the lit-
erature, an associative memory constitutes a content-
addressable neural network based upon matrix al-
gebra [27] that connects each input vector x with
its corresponding output vector y. In practice, the
associative memory takes the form of a connection
weight matrix W = [wi,j]C×G built from a finite
set of n encoded associations, generally known as
fundamental set of associations, {(xµ,yµ) | µ =
1, 2, . . . , n}, where xµ ∈ RG correspond to the fun-
damental input samples of dimension G and yµ ∈
RC are the fundamental output samples of dimen-
sion C. Then xµj represents the j-th element of an
input sample xµ, and yµi indicates the i-th element
of an output sample yµ.
In general, an associative memory can be of two
types depending on the nature of memorized associ-
ations: hetero-associative (e.g., lernmatrix [41], lin-
ear associator [4,26], alpha-beta associative mem-
ory [48]) and auto-associative (e.g., associatron [36],
Hopfield network [21], chaotic neural network [2],
bidirectional associative memory [28]). The hetero-
associative memories connect input samples with
output samples of different nature and formats (i.e.,
xµ 6= yµ), whereas the auto-associative neural net-
works are viewed as a particular case of the former
where xµ = yµ and G = C. On the other hand,
while the auto-associative models include a single
layer in which all processing units are completely
connected by feedback links, the hetero-associative
memories consist of more than one layer and each
layer is fully connected to all the others.
Since the seminal works of Steinbuch [41], An-
derson [4], Kohonen [26] and Nakano [36], asso-
ciative memories have gradually been the subject
of many theoretical and empirical studies. For in-
stance, the bidirectional associative memory was ap-
plied to the diagnosis of cancer based on the el-
emental contents in serum samples [50]. Chartier
and Lepage [11] developed a modified Hopfield net-
work to learn and detect edges from gray level im-
ages. Arya et al. [6] implemented a face recogni-
tion system using auto-associative memory blocks
in parallel. A technique for segmentation and clas-
sification of soft tissues from textural features of
medical images based on a bidirectional associative
memory was designed by Sharma et al. [40]. Sudo
et al. [42] introduced a new associative memory ca-
pable of realizing both bidirectional and multidirec-
tional associations. Aldape-Pérez et al. [3] proposed
the use of an associative neural network for medi-
cal decision support systems. Aghajari et al. [1] sug-
gested a chaotic hetero-associative memory built us-
ing a learning strategy that allows to store and re-
call a set of associated patterns even when these
are noisy. Vaishnavi et al. [44] adapted the Hopfield
network for isolated word recognition. Villuendas-
Rey et al. [45] presented the naı̈ve associative clas-
sifier, which was based upon a new similarity op-
erator with the capability to handle missing values
and both numerical and categorical data. Cleofas-
Sánchez et al. [12] built an associative memory with
a translation of the coordinate axes for financial dis-
tress prediction, showing higher performance than
other classifiers especially when the data sets ex-
hibited some overlapping and severe imbalance in
class distribution.
Henceforth, the article is organized as follows.
Section 2 provides a detailed description of the two-
stage hetero-associative neural network that we pro-
pose here. The databases and experimental set-up
are outlined in Section 3, whereas the classification
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results are reported and discussed in Section 4. Fi-
nally, Section 5 summarizes the most remarkable
findings that can be gathered from this study and
identifies some avenues for further research.
2 The two-stage associative memory
The two-level algorithm presented in this paper is
based on a particular implementation of an hetero-
associative memory, which combines the learning
stage of the linear associator with the recall stage
of the Steinbuch’s lernmatrix. This approach differs
from the hybrid associative memory introduced by
Cleofas-Sánchez et al. [12] in that the former in-
corporates a feature selection stage into the original
model, whereas this was merely designed for class
prediction. Since our method merges feature selec-
tion and classification based on associative mem-
ories, it will be here referred to as hybrid hetero-
associative memory (HAM).
It is worth highlighting that the main advantages
of this model over the linear associator and the lern-
matrix are two-fold: (i) it can work with real-valued
input samples, whereas the lernmatrix only accepts
the values 0 and 1; and (ii) the input vectors are
not constrained to be orthonormal, unlike the lin-
ear associator. Besides, it has to be mentioned that
the hetero-associative memories are generally con-
sidered to be tolerant to noise on the input and in-
complete stimuli.
2.1 Level 1: Construction of the hetero-associative
memory
The first level of the HAM algorithm is devoted to
building a matrix W such that when an input sam-
ple xµ is presented, the stored sample yµ associated
with it will be retrieved. This matrix construction
process consists of two sequential steps:
1. For each encoded association (xµ,yµ), calcu-
late the outer product yµ(xµ)T , where (xµ)T
corresponds to the transpose of xµ.




µ(xµ)T , where α denotes the
normalizing constant (usually set to 1/n). The







Moreover, it has to be pointed out that the learn-
ing stage of this hetero-associative memory starts
by translating the coordinate axes to an origin lo-
cated at the centroid of the fundamental input sam-
ples. The purpose of moving the fundamental set is
to represent the input samples in a newG-dimensional
space where samples that belong to two different
classes are located diametrically opposite to each
other, and the midpoint of the diameter is given by
the mean vector x, that is, the origin of the new co-
ordinate axes. This translation should provide higher
classification performance because it is expected that
samples of different classes will probably be put
quite far apart in separate quadrants.
Let A = {x1,x2, . . . ,xn} be a finite set of n
fundamental input samples, let C denote the num-
ber of classes, and let Â = {x̂1, x̂2, . . . , x̂n} be the
set of fundamental input samples translated to the
new space. Then the pseudo-code of the learning
stage to build the connection weight matrix W is
presented in Algorithm 1, which is based on the as-
sociative memory proposed by Cleofas-Sánchez et
al. [12].
Algorithm 1 Construction stage
1: s← 0
2: for all xµ ∈ A do
3: s← s+ xµ
4: end for
5: x← s/n
6: for all xµ ∈ A do
7: x̂µ ← xµ − x
8: k ← 1
9: while k ≤ C do
10: if class(x̂µ) = k then
11: yµk = 1
12: else
13: yµk = 0
14: end if




19: for all (x̂µ,yµ) do
20: W←W+ (yµ)(x̂µ)T
21: end for
2.2 Level 2: Feature selection
Let Eµi,j be the error of classifying a sample x̂
µ to
class i based on gene j expressed as,
Eµi,j =
{







Then the cumulative classification error for gene
j can be defined as,







and let Θ be a reference value calculated from the









Now we can construct a G-dimensional vector
V whose j-th element is obtained as follows:
vj =
{
1 if (1− 1GEj) > Θ
0 otherwise
(4)
Note that those components of vector V whose
value is equal to 0 will correspond to genes that can
be deemed as irrelevant.
2.3 Classification using the HAM model
Once the matrix W and the vector V have been
constructed, the classification of a new input sample
x comprises two steps: (i) to obtain x̂ as a result of
translating x according to step 7 of Algorithm 1,
and (ii) to apply the recall stage of lernmatrix so
that x is assigned to some of the C classes.
The recall stage of lernmatrix consists of deter-
mining the elements of the vector yµ associated to
an input sample xµ. The i-th element yµi of the class

















If an input vector x̂µ is assigned to class k, this
function yields a C-dimensional output vector yµ
whose k-th element yµk is set to 1 and the rest of
elements yµj (j = 1, 2, . . . , k− 1, k+1, . . . , C) are
set to 0.
3 Experiments
Applicability and efficiency of the new model have
been analyzed by conducting a pool of experiments
on four gene-expression databases, which have been
gathered from a public repository available at http:
//datam.i2r.a-star.edu.sg/datasets/
krbd. Table 1 provides a quantitative comparison
of the databases used in the experiments, reporting
the number of genes (features), the cardinality of
the data set, the number of samples in each class,
and the imbalance ratio (the size of the majority
class divided by the size of the minority class). It
also includes the T2 measure (it describes the den-
sity of spatial distributions of samples by compar-
ing the number of samples in the data set to the
number of genes) [20].
As can be observed, the properties of the data
sets chosen for the experiments reflect the challeng-
ing ‘large G, small n’ problem mentioned in Sec-
tion 1, with small sample size ranging from 39 to
62 and high dimensionality ranging from 2000 to
7129 genes. This problem can be better seen by the
values of T2, which are all very low (ranging from
0.0084 in CNS to 0.0310 in Colon). Conversely, dif-
ferences in size between both classes are quite small
(less than two samples from the majority class per
each sample from the minority class) and therefore,
it appears that class imbalance should not represent
a critical problem for these databases.
The CNS data correspond to the outcome of a
treatment for central nervous system embryonal tu-
mor, where the survivors refer to individuals who
are alive after receiving the prescribed treatment and
the failures are patients who passed away. The Colon
database consists of 62 samples collected from in-
dividuals with colorectal cancer; the samples can
be tumor or normal tissues (gathered from healthy
parts of the colons of the same individuals). The
DLBCL-Standford database collects samples from
two groups of patients according to the gene expres-
sion profiling of diffuse large B-cell lymphoma: one
group has gene expression characteristics of germi-
nal center B cells, and the other group corresponds
to genes normally induced during in vitro activa-
tion of peripheral blood B cells. Finally, the Lung-
Ontario database includes gene-expression microar-
rays of individuals with non-small cell lung cancer,
indicating whether they experienced relapse of their
tumor or they are disease-free.
It has to be noted that both DLBCL-Standford
and Lung-Ontario databases contain several features
with missing values. Therefore, to apply the classi-
fication models, these data sets have been prepro-
cessed using the K-means clustering technique for
missing data imputation [22,32].
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Table 1 Some characteristics of the databases
# Genes # Samples Class1 – Class2 Imbalance T2
CNS 7129 60 Failure (21) – Survivor (39) 1.86 0.0084
Colon 2000 62 Tumor (40) – Normal (22) 1.82 0.0310
DLBCL-Standford 4026 47 Germinal (24) – Activated (23) 1.04 0.0117
Lung-Ontario 2880 39 Relapse (24) – No relapse (15) 1.60 0.0135
3.1 Experimental design
We compared the two-level hetero-associative mem-
ory (HAM) against five standard prediction models:
the nearest neighbor (NN) classifier with the Eu-
clidean distance function, a support vector machine
(SVM), a multi-layer perceptron network (MLP), a
C4.5 decision tree, and a random forest (RF). The
architectures and parameter settings of each model
were defined as follows. The MLP neural network
was designed with the Broyden-Fletcher-Goldfarb-
Shanno (BFGS) optimization algorithm, two neu-
rons in the hidden layer, a sigmoid transfer function,
the backpropagation learning algorithm, a learning
rate α = 0.1 and a maximum number of training
epochs equal to 10000; the SVM employed a lin-
ear kernel because this has been deemed as one of
the best performing functions in numerous biomed-
ical applications [8], using a soft-margin constant
equal to 1.0, a tolerance of 0.001, a round-off er-
ror ε = 1.0E–12 and the sequential minimal opti-
mization algorithm; the C4.5 classifier was applied
with a pruning confidence factor of 0.25; and each
bag in the RF contained all training samples and the
number of iterations was equal to 100. We also in-
cluded the associative memory without feature se-
lection (ASM) [12] to gain a better understanding
of the behavior of HAM.
The five-fold cross-validation method was used
in this study because it seems to be more appro-
priate and statistically safe than other well-known
techniques, such as holdout with the need of large
data sets to achieve good generalization or boot-
strapping with critical assumptions to be taken (e.g.,
independence of samples and large data size) [10,
24]. Each original set was randomly split into five
stratified portions of equal size; for each fold, four
parts were merged to build a training set, and the
remaining block was put aside to have an indepen-
dent set for testing purposes. Then the final scores
presented in next section will correspond to the av-
erage of the five trials.
3.2 Performance assessment criteria
In general, most biological and biomedical applica-
tions need to evaluate not only the overall accuracy,
but also the true-positive and true-negative hits be-
cause of the asymmetric costs of false-positives and
false-negatives [29,34]. Hence the performance of
the algorithms has been here evaluated using three
measures calculated from a 2× 2 confusion matrix,





TP + FN + TN + FP
× 100












where TP and TN refer to the total amount of pos-
itive and negative samples correctly predicted re-
spectively, whileFP andFN indicate the total num-
ber of mispredictions on negative and positive sam-
ples respectively.
Note that in the present study, the samples that
belong to class1 have been considered to mold the
positive class and the samples from class2 have com-
prised the negative class.
4 Results
Table 2 reports the classification accuracy for each
database using the six prediction algorithms. The
best performing model for each database is shown
in boldface. The results indicate that no method per-
formed the best for all databases, which reveals the
complexity of tumor classification because of the
heterogeneity of gene-expression microarray data.
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In general, the SVM was superior to the rest
of algorithms (in fact, this was already known in
microarray literature), but the HAM approach per-
formed equally well as SVM on the CNS, and even
better on DLBCL-Standford. In the case of CNS,
NN and C4.5 appear not to be appropriate choices
because their accuracy was very close to the perfor-
mance of the random-guess classifier (i.e., accuracy
≈ 50.00%). Similar comments can be drawn for the
NN and MLP models on the Lung-Ontario database
where their accuracy was 58.97%, and also for ASM
with an accuracy of 61.43%. Regarding the Colon
database, the C4.5 decision tree and MLP were the
best (83.87%) and the worst (69.35%) algorithms
respectively, while there were no remarkable differ-
ences between HAM, NN, SVM, RF, and ASM.
Table 2 Classification accuracy
CNS Colon DLBCL Lung
HAM 68.33 79.03 96.00 75.64
NN 56.67 75.81 74.47 58.97
MLP 65.00 69.35 93.62 58.97
SVM 68.33 80.65 95.74 79.49
C4.5 55.00 83.87 70.21 74.36
RF 61.67 79.03 91.49 69.23
ASM 67.69 77.69 90.88 61.43
Table 3 summarizes some descriptive statistics
of the accuracy results for a complete understanding
of the differences between the six prediction mod-
els. It can be seen that the classifier with the high-
est average accuracy corresponds to SVM, closely
followed by the HAM method. The ranges between
the maximum and minimum values of these two al-
gorithms were similar, revealing that differences in
accuracy were not critical.
Table 3 Descriptive statistics of accuracy results
Range Q1 Q3 Mean Std. Dev.
HAM 27.67 73.81 83.27 79.75 11.72
NN 19.14 58.40 74.81 66.48 10.06
MLP 37.35 63.49 76.09 72.41 16.50
SVM 27.41 76.70 84.42 81.05 11.26
C4.5 28.87 66.41 76.74 70.86 12.02
RF 29.82 67.34 82.15 75.36 12.89
ASM 29.45 66.13 80.99 74.42 12.85
Since the above observations result subjective
and qualitative in nature, statistical tests can pro-
vide more objective insights into whether there exist
some statistically significant differences. Our first
step was to determine whether the data is approx-
imately normally distributed. To this end, we run
Shapiro-Wilk, Lilliefors and Jarque-Bera tests be-
cause graphical methods such as the frequency dis-
tribution and Q-Q plots are not very useful when the
sample size is small. Thus the null and alternative
hypotheses for the normality tests were:
– H0: The data follow a normal distribution.
– H1: The data do not follow a normal distribu-
tion.
Results of Shapiro-Wilk, Lilliefors and Jarque-
Bera tests are shown in Table 4. All normality tests
failed to reject the null hypothesis (p-value< 0.05),
which means that there is not enough evidence to
conclude that the data do not follow a normal dis-
tribution.
Table 4 Normality tests
Shapiro-Wilk Lilliefors Jarque-Bera
HAM 0.599 0.356 0.805
NN 0.133 0.293 0.727
MLP 0.236 0.147 0.710
SVM 0.732 0.416 0.895
C4.5 0.857 0.651 0.869
RF 0.912 0.909 0.845
ASM 0.896 0.901 0.835
As the normality assumption was not rejected,
we performed paired sample t-tests between the set
of results corresponding to each pair of methods.
Thus we checked whether the mean of accuracies of
one model Mi was more significant than the mean
of accuracies of another model Mj at the 95% con-
fidence level. In this case, the null and alternative
hypotheses for the t-tests were:
– H0: The difference between the means is equal
to 0.
– H1: The difference between the means is differ-
ent from 0.
We rejected the null hypothesis H0 and accepted
the alternative hypothesis H1 if the p-value was less
than 0.05.
The numbers marked as bold in Table 5 indicate
that the paired sample t-test rejected the null hy-
pothesis (p-value < 0.05). It can be observed that
the only cases with statistically significant differ-
ences corresponded to the test between HAM and
NN and the test between SVM and NN. Neverthe-
less, the risk to reject the null hypothesis H0 while
it is true was low for the comparisons of HAM and
SVM with the rest of models.
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Table 5 Paired sample t-tests
(1) (2) (3) (4) (5) (6) (7)
(1) HAM 0.04 0.14 0.26 0.28 0.07 0.19
(2) NN 0.40 0.03 0.41 0.06 0.11
(3) MLP 0.19 0.89 0.52 0.53
(4) SVM 0.19 0.05 0.19
(5) C4.5 0.52 0.68
(6) RF 0.76
(7) ASM
To analyze the differences between the two best
performing algorithms (HAM and SVM), we com-
puted four data complexity measures [20] that al-
low to quantify the overlap between classes (F1 and
F3) and the class separability (L1 and L2). Thus
we found that Colon constitutes a more complex
problem than DLBCL-Standford because the val-
ues of F1 and F3 were 1.083 and 0.000 for Colon,
and 2.907 and 0.016 for DLBCL-Standford. Anal-
ogously, the values of L1 and L2 were 0.498 and
0.000 for Colon, and 0.141 and 0.032 for DLBCL-
Standford. The reasons why we put our attention on
the accuracies for Colon and DLBCL-Standford are
two-fold: (i) the highest differences between SVM
and HAM were achieved for the Colon database,
and (ii) HAM outperformed SVM when applied to
the DLBCL-Standford data set.
Table 6 gives the number of genes selected by
the HAM method and the percentage of reduction
over the total amount of genes for each database. It
is worth remarking that the use of the hybrid hetero-
associative memory proposed here may enable sig-
nificant gains in computational speed and memory
because the irrelevant and/or redundant genes are
removed from the data sets. It was found that the
percentage of reduction was about 45–55% in av-
erage, which represents a quite meaningful amount
when the number of genes is very large (over thou-
sands of genes) as is the case of the microarray data
sets.
Table 6 Genes selected using the HAM model
CNS Colon DLBCL Lung
# Genes 3882 932 1727 1572
% Reduction 45.54 53.40 57.10 45.42
The use of accuracy to assess the prediction per-
formance is not the most suitable metric in real-
life problems with skewed class distributions and
unequal misclassification costs [25], as is the case
of tumor (cancer) classification/prediction. Besides,
this is also related to the likelihood of false-positives
as a result of the ‘largeG, small n’ problem in gene-
expression databases [15]. Hence we have also in-
cluded the values of sensitivity and specificity to
avoid potentially misleading conclusions drawn from
accuracy since this tends to be heavily biased to-
ward the majority class.
Figure 1 displays the classification procedures
in a space where the x-axis shows the sensitivity
and the y-axis depicts the specificity. In such a space,
a model with perfect prediction will be placed on
the upper right corner (100% sensitivity, 100% speci-
ficity) of the plot. Therefore, the closer the method
is to the upper right corner, the higher the classifica-
tion performance on both classes. Nevertheless, for
most biomedical applications it is better not to miss
a diagnosis of disease rather than to err in the classi-
fication of a non-tumor sample, which suggests that
maximizing the sensitivity (points close to the right
side) is of far more important than the specificity
(points close to the upper side).
One can observe that both HAM and SVM were
the algorithms with the most balanced trade-off be-
tween sensitivity and specificity, whereas the be-
havior of the remaining models depended on each
particular database, especially in the case of MLP
and RF. For instance, MLP applied to Lung-Ontario
data achieved about 80% of sensitivity and 25% of
specificity, which reveals that it misclassified many
negative samples. On the other hand, RF is located
close to the upper left corner of the plot (very low
sensitivity and high specificity), indicating that this
model failed on the prediction of most positive sam-
ples (the most important cases) and therefore, this
classifier is of no value at all for this specific prob-
lem. Finally, note that the associative memory with-
out feature selection also showed a right balance be-
tween sensitivity and specificity.
5 Conclusions
This paper has introduced a two-level algorithm for
tumor classification and characterization from gene-

































































































Fig. 1 Plots of sensitivity versus specificity for each database
expression microarray data. The proposed technique
comprises two stages: the first one aims to construct
a particular type of hetero-associative memory, and
the second level allows for the selection of the most
differentially expressed genes. The neural network
here designed corresponds to a combination of the
linear associator and the Steinbuch’s lernmatrix, and
it also includes an initial step in which the coordi-
nate axes are firstly translated to a new origin.
The HAM prediction model has been evaluated
on four gene-expression microarray databases and
empirically compared to five well-established clas-
sifiers (SVM, MLP, NN , C4.5, and RF) and also
to the associative memory without feature selection
(ASM) by measuring three scores: overall accuracy,
sensitivity and specificity. The results have shown
that the two-level hetero-associative memory has per-
formed similar to the best prediction model in most
cases, but it has also been observed that these com-
parisons strongly depend on the particular charac-
teristics of each database. However, importantly for
practical applications, an attractive advantage of the
HAM approach here introduced is the significant re-
duction in the number of genes used for classifica-
tion, which may lead to a considerable decrease in
computational requirements and help to increase its
biological interpretability.
The method proposed in this paper represents a
meaningful contribution to the collection of strate-
gies for the classification, characterization and anal-
ysis of gene-expression microarrays in cancer re-
search. However, it still constitutes a first step to-
wards exploring more complex hybridization tech-
niques that merge classification and feature selec-
tion through associative neural networks or other
emerging connectionist models (e.g., deep neural
networks), thus providing a better understanding of
medical decisions because a lower number of genes
should be analyzed. Another direction for further
research is to consider the HAM algorithm as a fea-
ture selection method for other classifiers.
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